Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06329687 · ClinicalTrials.gov registry record · Phase 4
A Study Evaluating the Safety of the Nasal Pump
A Phase 4 study, sponsored by Oyster Point Pharma.
- Terminated
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT06329687 is a Phase 4 study that was terminated before completion, run by Oyster Point Pharma. The registered enrollment target is 5 participants.
The verdict
NCT06329687, a Phase 4 study, was terminated before completion, sponsored by Oyster Point Pharma.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
The objective of this study is to determine the safety of the Tyrvaya nasal pump.
Interventions
- DRUG Tyrvaya Nasal Pump
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2024-02-21 |
| Est. Completion | 2024-02-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06329687
The ClinicalTrials.gov registry entry for NCT06329687 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oyster Point Pharma, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tyrvaya Nasal Pump is the first listed.
NCT06329687 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06329687 about?
NCT06329687 is a clinical study titled "A Study Evaluating the Safety of the Nasal Pump". The objective of this study is to determine the safety of the Tyrvaya nasal pump.
What is the current status of trial NCT06329687?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2024-02-21. Estimated completion is 2024-02-28.
What interventions are being tested in trial NCT06329687?
The interventions under investigation include: Tyrvaya Nasal Pump (DRUG).
Who is sponsoring clinical trial NCT06329687?
This trial is sponsored by Oyster Point Pharma, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.